KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.

Source:http://linkedlifedata.com/resource/pubmed/id/7651358

Download in:

View as

General Info

PMID
7651358